Remedy Entertainment (CHIX:REMEDH) Research & Development: €0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:REMEDH Remedy Entertainment PLC CHIX:REMEDH
81 GF Score
Price €15.14
GF Value €27.57
! 4 Warning Signs
View Full Analysis

What is Remedy Entertainment Research & Development?

Remedy Entertainment CHIX:REMEDH 81 Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus rates CHIX:REMEDH with a GF Score™ of 81/100 and a GF Value™ of €27.57. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Remedy Entertainment's Research & Development for the three months ended in Mar. 2026 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.

Remedy Entertainment  (CHIX:REMEDh) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Remedy Entertainment Research & Development Related Terms

Remedy Entertainment Research & Development Historical Data

* Premium members only.

The historical data trend for Remedy Entertainment's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remedy Entertainment Research & Development Chart

Remedy Entertainment Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Remedy Entertainment Quarterly Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:REMEDH
81GF Score
Remedy Entertainment PLC CHIX:REMEDH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Remedy Entertainment Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Remedy Entertainment (CHIX:REMEDH) has a Research & Development of €0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Remedy Entertainment and its competitors.
Is Remedy Entertainment's Research & Development too high?
Remedy Entertainment's current Research & Development is €0.00 Mil. Overall, Remedy Entertainment has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Remedy Entertainment's Research & Development compare to NTES and EA?
Remedy Entertainment's Research & Development of €0.00 Mil can be compared against companies in the Interactive Media industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Interactive Media company?
A good Research & Development depends on the Interactive Media industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Remedy Entertainment and its competitors. Remedy Entertainment's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Remedy Entertainment stock overvalued right now?
Remedy Entertainment (CHIX:REMEDH) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €27.57, compared to a current price of €15.14 — trading 45.1% below its estimated fair value. The current Research & Development is €0.00 Mil. Remedy Entertainment's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Remedy Entertainment (CHIX:REMEDH), the current Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Remedy Entertainment (CHIX:REMEDH) Overvalued in 2026?

Based on GuruFocus' analysis, Remedy Entertainment stock appears to be undervalued. The current stock price of €15.14 is trading 45.1% below its estimated GF Value™ of €27.57.

Key valuation signals for CHIX:REMEDH:

  • Research & Development: €0.00 Mil
  • GF Value™: €27.57 vs. price of €15.14 (45.1% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the CHIX:REMEDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Remedy Entertainment Business Description

Other Exchanges REMEDY:Finland8P8:Germany
Address Luomanportti 3, Espoo, FIN, 02200
Remedy Entertainment PLC is a gaming company developing narrative and visually impressive console and computer games, published by partners such as Rockstar Games and Smile Gate, Sony and Microsoft. The company's games have been made into books, comics, concerts, Tv-series, and a Hollywood movie. It published games such as Death Rally, Max Payne, and others. It has a Games Market segment that includes Mobile, Console, and PC.
81GF Score

Get the complete analysis for CHIX:REMEDH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.14
Price
€27.57
GF Value